MDA-7/IL-24 as a cancer therapeutic: From bench to bedside

Anti-Cancer Drugs

Volumn 21, Issue 8, 2010, Pages 725-731

  Dent, Paul ^a   Yacoub, Adly ^a   Hamed, Hossein A ^a   Park, Margaret A ^a   Dash, Rupesh ^a   Bhutia, Sujit K ^a   Sarkar, Devanand ^a   Gupta, Pankaj ^a   Emdad, Luni ^e   Lebedeva, Irina V ^f   Sauane, Moira ^f   Su, Zhao Zhong ^a   Rahmani, Mohamed ^b   Broaddus, William C ^a   Young, Harold F ^a   Lesniak, MacIej ^d   Grant, Steven ^a,b   Curiel, David T ^c   Fisher, Paul B ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

^f NONE   (United States)

Author keywords

apoptosis; autophagy; melanoma differentiation associated gene 7

Indexed keywords

ADENOVIRUS VECTOR; CERAMIDE; INTERLEUKIN 24; REACTIVE OXYGEN METABOLITE;

ADENOCARCINOMA; ADENOVIRUS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER INHIBITION; CANCER THERAPY; CELL DEATH; CELL TRANSFORMATION; CHROMOSOME; CYTOTOXICITY; DRUG RESPONSE; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; GLIOBLASTOMA; HUMAN; IN VITRO STUDY; LIP CARCINOMA; LUNG NON SMALL CELL CANCER; LYSOSOME; MELANOMA; NONHUMAN; PENIS CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; RADIOSENSITIZATION; REVIEW; SIGNAL TRANSDUCTION; SUBTRACTIVE HYBRIDIZATION; TUMOR CELL; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; APOPTOSIS; CELL LINE, TUMOR; CYTOKINES; FEMALE; GENE THERAPY; GENES, TUMOR SUPPRESSOR; HUMANS; INTERLEUKINS; MALE; MIDDLE AGED; NEOPLASMS; RADIATION TOLERANCE; SIGNAL TRANSDUCTION;

EID: 77955230157     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/CAD.0b013e32833cfbe1     Document Type: Review

References (74)

1. Jiang H, Su ZZ, Boyd J, Fisher PB. Gene expression changes associated with reversible growth suppression and the induction of terminal differentiation in human melanoma cells. Mol Cell Differ 1993; 1:41-66.
2. Jiang H, Fisher PB. Use of a sensitive and efficient subtraction hybridization protocol for the identification of genes differentially regulated during the induction of differentiation in human melanoma cells. Mol Cell Differ 1993; 1:285-299.
3. Jiang H, Lin JJ, Su ZZ, Goldstein NI, Fisher PB. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene 1995; 11:2477-2486.
4. Huang EY, Madireddi MT, Gopalkrishnan RV, Leszczyniecka M, Su ZZ, Lebedeva IV, et al. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties. Oncogene 2001; 20:7051-7063.
5. Wolk K, Kunz S, Asadullah K, Sabat R. Cutting edge: immune cells as sources and targets of the IL-10 family members? J Immunol 2002; 168:5397-5402.
6. Ellerhorst JA, Prieto VG, Ekmekcioglu S, Broemeling L, Yekell S, Chada S, et al. Loss of MDA-7 expression with progression of melanoma. J Clin Oncol 2002; 20:1069-1074.
7. Ekmekcioglu S, Ellerhorst J, Mhashilkar AM, Sahin AA, Read CM, Prieto VG, et al. Downregulated melanoma differentiation associated gene (mda-7) expression in human melanomas. Int J Cancer 2001; 94:54-59.
8. Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB. Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 2004; 22:929-979.
9. Kotenko SV. The family of IL-10-related cytokines and their receptors: related, but to what extent? Cytokine Growth Factor Rev 2002; 13:223-240.
10. Pestka S, Kotenko SV, Fisher PB. IL-24. In: Henry HL, Norman AW, editors. Encyclopedia of hormones. San Diego, CA: Academic Press; 2003. 507-513
11. Caudell EG, Mumm JB, Poindexter N, Ekmekcioglu S, Mhashilkar AM, Yang XH, et al. The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7, exhibits immunostimulatory activity and is designated IL-24. J Immunol 2002; 168:6041-6046.
12. Jiang H, Su ZZ, Lin JJ, Goldstein NI, Young CS, Fisher PB. The melanoma differentiation associated gene mda-7 suppresses cancer cell growth. Proc Natl Acad Sci USA 1996; 93:9160-9165.
13. Parrish-Novak J, Xu W, Brender T, Yao L, Jones C, West J, et al. Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions. J Biol Chem 2002; 277:47517-47523.
14. Chada S, Mhashilkar AM, Ramesh R, Mumm JB, Sutton RB, Bocangel D, et al. Bystander activity of Ad-mda7: human MDA-7 protein kills melanoma cells via an IL-20 receptor-dependent but STAT3-independent mechanism. Mol Ther 2004; 10:1085-1095.
15. Sauane M, Gopalkrishnan RV, Lebedeva I, Mei MX, Sarkar D, Su ZZ, et al. Mda-7/IL-24 induces apoptosis of diverse cancer cell lines through JAK/ STAT-independent pathways. J Cell Physiol 2003; 196:334-345.
16. Emdad L, Lebedeva IV, Su ZZ, Gupta P, Sauane M, Dash R, et al. Historical perspective and recent insights into our understanding of the molecular and biochemical basis of the antitumor properties of mda-7/IL-24. Cancer Biol Ther 2009; 8:391-400.
17. Lebedeva IV, Emdad L, Su ZZ, Gupta P, Sauane M, Sarkar D, et al. mda-7/IL-24, novel anticancer cytokine: focus on bystander antitumor, radiosensitization and anti-angiogenic properties and overview of the phase I clinical experience (Review). Int J Oncol 2007; 31:985-1007.
18. Nishikawa T, Ramesh R, Munshi A, Chada S, Meyn RE. Adenovirus- mediated mda-7 (IL24) gene therapy suppresses angiogenesis and sensitizes NSCLC xenograft tumors to radiation. Mol Ther 2004; 9:818-828.
19. Pataer A, Bocangel D, Chada S, Roth JA, Hunt KK, Swisher SG. Enhancement of adenoviral MDA-7-mediated cell killing in human lung cancer cells by geldanamycin and its 1 7-allyl- amino-1 7-demethoxy analogue. Cancer Gene Ther 2007; 14:12-18.
20. Chada S, Sutton RB, Ekmekcioglu S, Ellerhorst J, Mumm JB, Leitner WW, et al. MDA-7/ IL-24 is a unique cytokine-tumor suppressor in the IL-10 family. Int Immunopharmacol 2004; 4:649-667.
21. Gupta P, Walter MR, Su ZZ, Lebedeva IV, Emdad L, Randolph A, et al. BiP/GRP78 is an intracellular target for MDA-7/IL-24 induction of cancer- specific apoptosis. Cancer Res 2006; 66:8182-8191.
22. Yacoub A, Park MA, Gupta P, Rahmani M, Zhang G, Hamed H, et al. Caspase-, cathepsin and PERK-dependent regulation of MDA-7/ IL-24-induced cell killing in primary human glioma cells. Mol Cancer Ther 2008; 7:297-313.
23. Yacoub A, Hamed HA, Allegood J, Mitchell C, Spiegel S, Lesniak MS, et al. PERK-dependent regulation of ceramide synthase 6 and thioredoxin play a key role in mda-7/IL-24-induced killing of primary human glioblastoma multiform cells. Cancer Res 2010; 70:1120-1129.
24. Hamed HA, Yacoub A, Park MA, Eulitt P, Sarkar D, Dimitriev IP, et al. OSU- 03012 enhances Ad.mda-7-induced GBM cell killing via ER stress and autophagy and by decreasing expression of mitochondrial protective proteins. Cancer Biol Ther 2010; 9. [Epub ahead of print]
25. Yacoub A, Liu R, Park MA, Hamed HA, Dash R, Schramm DN, et al. Cisplatin enhances protein kinase R-like endoplasmic reticulum kinase- and CD95- dependent melanoma differentiation-associated gene-7/interleukin-24- induced killing in ovarian carcinoma cells. Mol Pharmacol 2010; 77:298-310.
26. Park MA, Walker T, Martin AP, Allegood J, Vozhilla N, Emdad L, et al. MDA-7/ IL-24-induced cell killing in malignant renal carcinoma cells occurs by a ceramide/CD95/PERK-dependent mechanism. Mol Cancer Ther 2009; 8:1280-1291.
27. Pataer A, Vorburger SA, Barber GN, Chada S, Mhashilkar AM, Zou-Yang H, et al. Adenoviral transfer of the melanoma differentiation-associated gene 7 (mda7) induces apoptosis of lung cancer cells via upregulation of the double-stranded RNA-dependent protein kinase (PKR). Cancer Res 2002; 62:2239-2243.
28. Pataer A, Vorburgerm SA, Chada S, Balachandran S, Barber GN, Roth JA, et al. Melanoma differentiation-associated gene-7 protein physically associates with the double-stranded RNA activated protein kinase PKR. Mol Ther 2005; 11:71 7-723.
29. Fels DR, Koumenis C. The PERK/eIF2a/ATF4 Module of the UPR in hypoxia resistance and tumor growth. Cancer Biol Ther 2006; 5:723-728.
30. Raven JF, Koromilas AE. PERK and PKR: old kinases learn new tricks. Cell Cycle 2008; 7:1146-1150.
31. Fritsch RM, Schneider G, Saur D, Scheibel M, Schmid RM. Translational repression of MCL-1 couples stress-induced eIF2 alpha phosphorylation to mitochondrial apoptosis initiation. J Biol Chem 2007; 282:22551-22562.
32. Su ZZ, Lebedeva IV, Sarkar D, Emdad L, Gupta P, Kitada S, et al. Ionizing radiation enhances therapeutic activity of mda-7/IL-24: Overcoming radiation- and mda-7/IL-24- resistance in prostate cancer cells overexpressing the antiapoptotic proteins bcl-xL or bcl-2. Oncogene 2006; 25:2339-2348.
33. Lebedeva IV, Sarkar D, Su ZZ, Kitada S, Dent P, Stein CA, et al. Bcl-2 and Bcl-xL differentially protect human prostate cancer cells from induction of apoptosis by melanoma differentiation associated gene-7, mda-7/IL-24. Oncogene 2003; 22:8758-8773.
34. Sauane M, Su ZZ, Dash R, Liu X, Norris JS, Sarkar D, et al. Ceramide plays a prominent role in MDA-7/IL-24-induced cancer-specific apoptosis. J Cell Physiol, 2010; 222: 546-555
35. Bhutia SK, Dash R, Das SK, Azab B, Su ZZ, Lee SG, et al. Mechanism of autophagy to apoptosis switch triggered in prostate cancer cells by antitumor cytokine melanoma differentiation-associated gene 7/interleukin- 24. Cancer Res 2010; 70:3667-3676.
36. Sarkar D, Lebedeva IV, Gupta P, Emdad L, Sauane M, Dent P, et al. Melanoma differentiation associated gene-7 (mda-7)/IL-24: a 'magic bullet' for cancer therapy? Expert Opin Biol Ther 2007; 7:577-586.
37. Gupta P, Su ZZ, Lebedeva IV, Sarkar D, Sauane M, Emdad L, et al. mda-7/ IL-24: multifunctional cancer-specific apoptosis-inducing cytokine. Pharmacol Ther 2006; 111:596-628.
38. Lebedeva IV, Washington I, Sarkar D, Clark JA, Fine RL, Dent P, et al. Strategy for reversing resistance to a single anticancer agent in human prostate and pancreatic carcinomas. Proc Natl Acad Sci USA 2007; 104:3484-3489.
39. Fisher PB, Sarkar D, Lebedeva IV, Emdad L, Gupta P, Sauane M, et al. Melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24): novel gene therapeutic for metastatic melanoma. Toxicol Appl Pharmacol 2007; 224:300-307.
40. Lebedeva IV, Su ZZ, Sarkar D, Kitada S, Dent P, Waxman S, et al. Melanoma differentiation associated gene-7, mda-7/interleukin-24, induces apoptosis in prostate cancer cells by promoting mitochondrial dysfunction and inducing reactive oxygen species. Cancer Res 2003; 63:8138-8144.
41. Inoue S, Shanker M, Miyahara R, Gopalan B, Patel S, Oida Y, et al. MDA-7/ IL-24-based cancer gene therapy: translation from the laboratory to the clinic. Curr Gene Ther 2006; 6:73-91.
42. Tong AW, Nemunaitis J, Su D, Zhang Y, Cunningham C, Senzer N, et al. Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer patients. Mol Ther 2005; 11:160-1 72.
43. Cunningham CC, Chada S, Merritt JA, Tong A, Senzer N, Zhang Y, et al. Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I study. Mol Ther 2005; 11:149-159.
44. Eager R, Harle L, Nemunaitis J. Ad-MDA-7; INGN 241: a review of preclinical and clinical experience. Expert Opin Biol Ther 2008; 8:1633-1643.
45. Sauane M, Lebedeva IV, Su ZZ, Choo HT, Randolph A, Valerie K, et al. Melanoma differentiation associated gene-7/interleukin-24 promotes tumor cell-specific apoptosis through both secretory and nonsecretory pathways. Cancer Res 2004; 64:2988-2993.
46. Su ZZ, Emdad L, Sauane M, Lebedeva IV, Sarkar D, Gupta P, et al. Unique aspects of mda-7/IL-24 antitumor bystander activity: establishing a role for secretion of MDA-7/IL-24 by normal cells. Oncogene 2005; 24:7552-7566.
47. Sauane M, Gupta P, Lebedeva IV, Su ZZ, Sarkar D, Randolph A, et al. N-glycosylation of MDA-7/IL-24 is dispensable for tumor cell-specific apoptosis and 'bystander' antitumor activity. Cancer Res 2006; 66: 11869-11877.
48. Sauane M, Su ZZ, Gupta P, Lebedeva IV, Dent P, Sarkar D, Fisher PB. Autocrine regulation of mda-7/IL-24 mediates cancer-specific apoptosis. Proc Natl Acad Sci USA 2008; 105:9763-9768.
49. Park MA, Mitchell C, Hamed HA, Allegood J, Dmitriev IP, Ogretmen B, et al. A serotype 5/3 adenovirus expressing MDA-7/IL-24 infects renal carcinoma cells and promotes paracrine-induced MDA-7/IL-24 and apoptosis in uninfected cells. Mol Cancer Ther (submitted).
50. Pelicano H, Carney D, Huang P. ROS stress in cancer cells and therapeutic implications. Drug Resist Updat 2004; 7:97-110.
51. Valerie K, Yacoub A, Hagan MP, Curiel DT, Fisher PB, Grant S, et al. Radiation-induced cell signaling: inside-out and outside-in. Mol Cancer Ther 2007; 6:789-801.
52. Hagan MP, Yacoub A, Dent P. Radiation-induced PARP activation is enhanced through EGFR-ERK signaling. J Cell Biochem 2007; 101:1384-1393.
53. Stancevic B, Kolesnick R. Ceramide-rich platforms in transmembrane signaling. FEBS Lett 2010; 584:1728-1740.
54. Su ZZ, Lebedeva IV, Sarkar D, Gopalkrishnan RV, Sauane M, Sigmon C, et al. Melanoma differentiation associated gene-7, mda-7/IL-24, selectively induces growth suppression, apoptosis and radiosensitization in malignant gliomas in a p53-independent manner. Oncogene 2003; 22:1164-1180.
55. Emdad L, Sarkar D, Lebedeva IV, Su ZZ, Gupta P, Mahasreshti PJ,et al. Ionizing radiation enhances adenoviral vector expressing mda-7/IL-24- mediated apoptosis in human ovarian cancer. J Cell Physiol, 2006; 208: 298-306
56. Emdad L, Lebedeva IV, Su ZZ, Gupta P, Sarkar D, Settleman J, Fisher PB. Combinatorial treatment of non-small-cell lung cancers with gefitinib and Ad.mda-7 enhances apoptosis induction and reverses resistance to a single therapy. J Cell Physiol 2007; 210:549-559.
57. Yacoub A, Mitchell C, Lebedeva IV, Sarkar D, Su ZZ, McKinstry R, et al. mda-7 (IL-24) Inhibits growth and enhances radiosensitivity of glioma cells in vitro via JNK signaling. Cancer Biol Ther 2003; 2:347-353.
58. Kawabe S, Nishikawa T, Munshi A, Roth JA, Chada S, Meyn RE. Adenovirus- mediated mda-7 gene expression radiosensitizes non-small cell lung cancer cells via TP53-independent mechanisms. Mol Ther 2002; 6:637-644.
59. Mesicek J, Lee H, Feldman T, Jiang X, Skobeleva A, Berdyshev EV, et al. Ceramide synthases 2, 5, and 6 confer distinct roles in radiation-induced apoptosis in HeLa cells. Cell Signal 2010. [Epub ahead of print].
60. Su ZZ, Lebedeva IV, Gopalkrishnan RV, Goldstein NI, Stein CA, Reed JC, et al. A combinatorial approach for selectively inducing programmed cell death in human pancreatic cancer cells. Proc Natl Acad Sci USA 2001; 98:10332-10337.
61. Lebedeva IV, Sarkar D, Su ZZ, Gopalkrishnan RV, Athar M, Randolph A, et al. Molecular target-based therapy of pancreatic cancer. Cancer Res 2006; 66:2403-2413.
62. Shanker M, Gopalan B, Patel S, Bocangel D, Chada S, Ramesh R. Vitamin E succinate in combination with mda-7 results in enhanced human ovarian tumor cell killing through modulation of extrinsic and intrinsic apoptotic pathways. Cancer Lett 2007; 254:21 7-226.
63. Oida Y, Gopalan B, Miyahara R, Inoue S, Branch CD, Mhashilkar AM, et al. Sulindac enhances adenoviral vector expressing mda-7/IL-24-mediated apoptosis in human lung cancer. Mol Cancer Ther 2005; 4:291-304.
64. Lebedeva IV, Su ZZ, Vozhilla N, Chatman L, Sarkar D, Dent P, et al. Chemoprevention by perillyl alcohol coupled with viral gene therapy reduces pancreatic cancer pathogenesis. Mol Cancer Ther 2008; 7:2042-2050.
65. Lebedeva IV, Su ZZ, Vozhilla N, Chatman L, Sarkar D, Dent P, et al. Mechanism of in vitro pancreatic cancer cell growth inhibition by melanoma differentiation-associated gene-7/interleukin-24 and perillyl alcohol. Cancer Res 2008; 68:7439-7447.
66. Yacoub A, Mitchell C, Brannon J, Rosenberg E, Qiao L, McKinstry R, et al. MDA-7 (interleukin-24) inhibits the proliferation of renal carcinoma cells and interacts with free radicals to promote cell death and loss of reproductive capacity. Mol Cancer Ther 2003; 2:623-632.
67. Sarkar D, Su ZZ, Lebedeva IV, Sauane M, Gopalkrishnan RV, Valerie K, et al. mda-7 (IL-24) Mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK. Proc Natl Acad Sci U S A 2002; 99:10054-10059.
68. Yacoub A, Gupta P, Park MA, Rhamani M, Hamed H, Hanna D, et al. Regulation of GST-MDA-7 toxicity in human glioblastoma cells by ERBB1, ERK1/2, PI3K, and JNK1-3 pathway signaling. Mol Cancer Ther 2008; 7:314-329.
69. Wagner EF, Nebreda AR. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 2009; 9:537-549.
70. Dent P, Yacoub A, Fisher PB, Hagan MP, Grant S. MAPK pathways in radiation responses. Oncogene 2003; 22:5885-5896.
71. Dent P, Yacoub A, Contessa J, Caron R, Amorino G, Valerie K, et al. Stress and radiation-induced activation of multiple intracellular signaling pathways. Radiat Res 2003; 159:283-300.
72. Yacoub A, Mitchell C, Hong Y, Gopalkrishnan RV, Su ZZ, Gupta P, et al. MDA-7 regulates cell growth and radiosensitivity in vitro of primary (non-established) human glioma cells. Cancer Biol Ther 2004; 3:739-751.
73. Yacoub A, Mitchell C, Lister A, Lebedeva IV, Sarkar D, Su ZZ, et al. Melanoma differentiation-associated 7 (interleukin 24) inhibits growth and enhances radiosensitivity of glioma cells in vitro and in vivo. Clin Cancer Res 2003; 9:3272-3281.
74. Greco A, Di Benedetto A, Howard CM, Kelly S, Nande R, Dementieva Y, et al. Eradication of therapy-resistant human prostate tumors using an ultrasound-guided site-specific cancer terminator virus delivery approach. Mol Ther 2010; 18:295-306.